Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects ≥13 years of age
- 17 November 2006
- Vol. 24 (47-48) , 6875-6885
- https://doi.org/10.1016/j.vaccine.2006.06.030
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Decline in Mortality Due to Varicella after Implementation of Varicella Vaccination in the United StatesNew England Journal of Medicine, 2005
- Hospitalizations for varicella in the United States, 1988 to 1999The Pediatric Infectious Disease Journal, 2002
- Persistence of Immunity to Live Attenuated Varicella Vaccine in Healthy AdultsClinical Infectious Diseases, 2002
- Development and Validation of a Gamma Interferon ELISPOT Assay for Quantitation of Cellular Immune Responses to Varicella-Zoster VirusClinical and Diagnostic Laboratory Immunology, 2001
- Varicella vaccination—a critical review of the evidenceArchives of Disease in Childhood, 2001
- Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practiceThe Pediatric Infectious Disease Journal, 1999
- Improving the brown-forsythe solution to the generalized behrens-fisher problemCommunications in Statistics - Simulation and Computation, 1997
- Costs And Benefits Of Routine Varicella Vaccination In German ChildrenThe Journal of Infectious Diseases, 1996
- Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccineThe Journal of Pediatrics, 1995